Revatio, a medication primarily containing Sildenafil Citrate IP 20 mg, is widely recognized for its efficacy in treating pulmonary arterial hypertension (PAH) and improving exercise capacity in both men and women. As a generic form of Sildenafil, Revatio offers a cost-effective solution for patients seeking relief from the symptoms of PAH. The standard dose, Revatio 20 mg, is carefully calibrated to provide optimal benefits while minimizing potential side effects. Additionally, its availability in tablet form ensures ease of use, with pricing structured to enhance accessibility for patients in need of this vital treatment. Known also by the brand name Assurans in some markets, Revatio's uses extend to improving blood flow and heart function, showcasing its versatility and importance in the pharmaceutical landscape.